Radiology - Technology Information Portal
Saturday, 23 November 2024
• Welcome to Radiology-TIP.com!
     • Sign in / Create account
 
 Radiology Database  - R - p7
SEARCH   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Ra-Ra Ra-Ra Ra-Ra Ra-Ra Ra-Ra Re-Re Re-Re Re-Re Ri-RO Ru-Ru
Region of Interest
(ROI) Keyboard controlled identification of a given area of an image for numerical analysis and the area of anatomy being scanned that is of particular importance in the image. This area can also be a volume, than called (VOI) volume of interest.
A ROI can be used for purposes such as calculation of pixel statistics. ROI measurements should be made with the smallest area and away from boarders and edges to avoid partial volume averaging.
• View DATABASE results for 'Region of Interest' (3).Open this link in a new window.
Regional Cerebral Blood Flow
(RCBF) The regional cerebral blood flow is the evaluation of blood circulation in individual brain sections.
• View DATABASE results for 'Regional Cerebral Blood Flow' (3).Open this link in a new window.
Reno-30®
Reno-30® is a radiopaque contrast agent indicated for retrograde or ascending pyelography. Retrograde pyelography does not include systemic administration of contrast media, so the risk of adverse reactions is extremely rare.

Drug Information and Specification
NAME OF COMPOUND
Diatrizoate meglumine
DEVELOPER
Bracco Diagnostics, Inc.
INDICATION
Retrograde pyelography
APPLICATION
Intravesical
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
Ionic
IODINE CONCENTRATION
141 mg/mL
15 mL
PREPARATION
Ready-to-use product
STORAGE
Store at 20-25° Celsius (68-77° Fahrenheit), protect from light.
PRESENTATION
50 mL vials
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Reno-60®
Reno-60® is radiopaque contrast agent with a wide range of indications. Reno-60 should be at body temperature when injected and may need to be warmed before use. Following intravascular injection, iodinated contrast materials are transported through the bloodstream to the kidneys and excreted by glomerular filtration.

Drug Information and Specification
NAME OF COMPOUND
Diatrizoate meglumine
DEVELOPER
Bracco Diagnostics, Inc.
INDICATION
Urography, angiography, arthrography, brain and body computed tomography
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
IODINE CONCENTRATION
282 mg/mL
Depending on imaging procedure
PREPARATION
Ready-to-use product
STORAGE
Store at 20-25° Celsius (68-77° Fahrenheit), protect from light.
PRESENTATION
50 mL vials
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
RenoCal®-76
RenoCal®-76 (diatrizoate meglumine and diatrizoate sodium) was used as a contrast agent. Bracco Diagnostics, Inc. stated that the production of Renocal-76 has been discontinued due to reduced demand.
Ra-RaRa-RaRa-RaRa-RaRa-RaRe-ReRe-ReRe-ReRi-RORu-Ru
 
Share This Page
Facebook
Twitter
LinkedIn

Look
      Ups
Radiology - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging
Copyright © 2008 - 2024 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2023-11-06 02:01:00]